.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

CLL

EP. 1: ASH 2020: Results From the Phase 1/2 BRUIN Trial

April 23rd 2021

Download Issue

EP. 2: ASH 2020: TRANSCEND-CLL-004 Study: Results of CAR-T Combination in R/R CLL or SLL

April 23rd 2021

Download Issue

EP. 3: ASH 2020: TRANSCEND-CLL-004 Study: Results of CAR-T Monotherapy in R/R CLL or SLL

April 23rd 2021

Download Issue

EP. 4: ASH 2020: Results From the UNITY-CLL Study of Ublituximab Doublet Versus Chemoimmunotherapy in CLL

April 23rd 2021

Download Issue

EP. 5: Results From the Phase 2 CAPTIVATE Study

April 23rd 2021

Download Issue

EP. 6: ASH 2020: Updated Results from the Murano Five-Year Analysis in R/R CLL

April 23rd 2021

Download Issue

Latest News

FDA Approves Vidaza for Rare Pediatric Blood Cancer

My Cancer Advocacy Keeps My Mom’s Legacy Alive

Educated Patient® MPN Summit Novel Agents & Clinical Trials in Myelofibrosis Presentation: May 7, 2022

Unmatched Energy and Passion for Cancer Care

View More Latest News